Experienced in CMV Retinitis

Pierre Frange

Paris, FR 
Experienced in CMV Retinitis
Paris, FR 
OverviewLocationsClinical Research

Overview

Pierre Frange practices in Paris, France. Mr. Frange is rated as an Experienced expert by MediFind in the treatment of CMV Retinitis. His top areas of expertise are HIV/AIDS, Fifth Disease, Primary Immunodeficiency (PID), Bone Marrow Transplant, and Lung Transplant.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of CMV Retinitis.

Gender
Male

Locations

Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
ANRS EP59 CLEAC : Physiopathological Study of Immunovirological Evolution of Perinatally HIV-1 Infected Children Depending on Early (Before 6 Months) or Late (After 2 Years) Antiretroviral Therapy Introduction.
ANRS EP59 CLEAC : Physiopathological Study of Immunovirological Evolution of Perinatally HIV-1 Infected Children Depending on Early (Before 6 Months) or Late (After 2 Years) Antiretroviral Therapy Introduction.
Enrollment Status: Unknown
Publish Date: January 18, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

130 Total Publications

Success and limitations of the French public health strategy after 2 years of large implementation of Respiratory Syncytial Virus prophylaxis: experience of a tertiary hospital (2018-2025).
Success and limitations of the French public health strategy after 2 years of large implementation of Respiratory Syncytial Virus prophylaxis: experience of a tertiary hospital (2018-2025).
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 31, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Frange's expertise for a condition
ConditionClose
      View All 45 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile